Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 4
2016 2
2017 7
2018 7
2019 6
2020 8
2021 8
2022 7
2023 10
2024 3
2025 16
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Martorelli MC, Pugliese N, Di Perna M, De Novellis D, Lombardi A, De Fazio L, Loglisci G, Peluso I, Molica M, Copia C, Ricco A, Bruzzese A, Mendicino F, De Fazio V, Santeramo TM, Bianco R, Monaco G, Fontana R, Guariglia R, Serio B, Luponio S, Della Corte AM, Malandrini A, Giudice V, Frigeri F, Tarantini G, Guarini A, Gentile M, Musto P, Annunziata M, Di Renzo N, Rossi M, Califano C, Pane F, Selleri C. Martorelli MC, et al. Among authors: pugliese n. Eur J Haematol. 2026 Jan;116(1):23-30. doi: 10.1111/ejh.70034. Epub 2025 Sep 16. Eur J Haematol. 2026. PMID: 40955124 Free PMC article.
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib.
Palandri F, Branzanti F, Bonifacio M, Elli EM, Morsia E, Farina M, Tiribelli M, Benevolo G, Beggiato E, Martino B, Caocci G, Pugliese N, Tieghi A, Crugnola M, Binotto G, Cavazzini F, Abruzzese E, Isidori A, Dedola A, Scalzulli E, Duminuco A, Tosoni L, Strazimiri A, Lemoli RM, Cilloni D, Bocchia M, Pane F, Sartor C, Heidel FH, Breccia M, Palumbo GA, Kuykendall AT. Palandri F, et al. Among authors: pugliese n. Cancer. 2025 Sep 1;131(17):e70062. doi: 10.1002/cncr.70062. Cancer. 2025. PMID: 40839414 Free PMC article.
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real-world study.
Palandri F, Marchetti M, Elli EM, Isidori A, Gianesello I, Sartor C, Pugliese N, Di Perna M, Morsia E, Gallo S, Itri F, Montefusco V, Crisà E, Biagi A, Beggiato E, Mulas O, Benevolo G, Abruzzese E, Santoro M, Iurlo A, Calistri E, Rossi M, Martino B, Tiribelli M, Fava C, Dizdari A, Crugnola M, Duminuco A, Votto A, Guerzoni S, Caocci G, Pane F, Lanza F, Branzanti F, Dedola A, Salvatore F, Heidel FH, Breccia M, Palumbo GA, Kuykendall AT, Lucchesi A, Galimberti S. Palandri F, et al. Among authors: pugliese n. Cancer. 2026 May 15;132(10):e70457. doi: 10.1002/cncr.70457. Cancer. 2026. PMID: 42118670 Free PMC article.
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design.
De Stefano V, Passamonti F, Palandri F, Ramundo F, Rossi E, Betti S, Fagiolo L, Guglielmelli P, Abagnale DP, Pugliese N, Cattaneo D, Iurlo A, Branzanti F, Dedola A, Catellani H, Tieghi A, Basso M, Calistri E, Elli EM, Masselli E, Morsia E, Benevolo G, Breccia M, de Fazio V, Di Perna M, Marchetti M, Santoro M, Tafuri A, Castiglioni C, Rotella C, Siragusa S, Vannucchi AM; PROSPERO Study group. De Stefano V, et al. Among authors: pugliese n. Ann Hematol. 2025 Jul;104(7):3553-3566. doi: 10.1007/s00277-025-06466-z. Epub 2025 Jul 18. Ann Hematol. 2025. PMID: 40679584 Free PMC article. Review.
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Duminuco A, Harrington P, Del Fabro V, Scalisi E, Santuccio G, Santisi A, Sbriglione A, Garibaldi B, Markovic U, Di Raimondo F, Palumbo GA, Pugliese N, Vetro C. Duminuco A, et al. Among authors: pugliese n. Pharmaceuticals (Basel). 2025 Aug 16;18(8):1212. doi: 10.3390/ph18081212. Pharmaceuticals (Basel). 2025. PMID: 40872603 Free PMC article. Review.
Splenectomy in Myelofibrosis: Indications, Efficacy, and Complications.
Malato A, Rossi E, Tiribelli M, Mendicino F, Pugliese N. Malato A, et al. Among authors: pugliese n. Clin Lymphoma Myeloma Leuk. 2020 Sep;20(9):588-595. doi: 10.1016/j.clml.2020.04.015. Epub 2020 Apr 30. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32482540 Free article. Review.
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.
Palandri F, Dedola A, Caocci G, Rossi E, Elli EM, Sartor C, Latagliata R, Pugliese N, Morsia E, Binotto G, Mendicino F, Tieghi A, Benevolo G, Martino B, D'Addio A, Tiribelli M, Cilloni D, Crugnola M, Cavalca F, Scalzulli E, Lanza F, Pane F, Palumbo GA, Heidel FH, De Stefano V, Breccia M, Branzanti F. Palandri F, et al. Among authors: pugliese n. Blood Adv. 2026 Aug 11;10(15):5469-5479. doi: 10.1182/bloodadvances.2026020255. Blood Adv. 2026. PMID: 42275537 Free PMC article.
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study.
Palandri F, Breccia M, Morsia E, Elli EM, Benevolo G, Tiribelli M, Beggiato E, Farina M, Caocci G, Pugliese N, Tieghi A, Crugnola M, Binotto G, Cavazzini F, Isidori A, Dedola A, Scalzulli E, Moioli A, Cavalca F, Caserta S, Duminuco A, Martino B, Lemoli RM, Cilloni D, Bocchia M, Pane F, Heidel FH, Bonifacio M, Palumbo GA, Branzanti F, Iurlo A, Abruzzese E. Palandri F, et al. Among authors: pugliese n. Leuk Res. 2025 Jul;154:107719. doi: 10.1016/j.leukres.2025.107719. Epub 2025 May 27. Leuk Res. 2025. PMID: 40460507 No abstract available.
Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma.
Travaglino A, Pace M, Varricchio S, Russo D, Pugliese N, Severino A, Picardi M, Pane F, Insabato L, Staibano S, Mascolo M. Travaglino A, et al. Among authors: pugliese n. Pathol Oncol Res. 2020 Oct;26(4):2075-2081. doi: 10.1007/s12253-020-00848-6. Epub 2020 Jun 18. Pathol Oncol Res. 2020. PMID: 32557170 Free article.
Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18-59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real-Life Series From Southern Italy Cancer Centers.
Picardi M, Vincenzi A, Giordano C, Pugliese N, Scarpa A, Lombardi A, Vigliar E, Troncone G, Cappiello R, Mascolo M, Esposito G, Prastaro M, Santoro C, Esposito R, Tocchetti CG, Mainolfi C, Fonti R, Del Vecchio S, Trastulli F, Annunziata M, Iula R, Califano C, Carchia M, Persico M, Salemme A, Nicolai E, Soricelli A, Salvatore M, Pane F. Picardi M, et al. Among authors: pugliese n. Eur J Haematol. 2026 Feb;116(2):174-184. doi: 10.1111/ejh.70060. Epub 2025 Nov 6. Eur J Haematol. 2026. PMID: 41198414 Free PMC article.
78 results